PharmaXcelerate 2026 is the leading regional platform dedicated to advancing excellence in pharmaceutical and biotech manufacturing, quality, and facility design. Taking place from 31 March – 2 April 2026 in Dubai, UAE, the summit will unite senior executives, manufacturing and quality leaders, regulators, and solution providers driving the future of compliant and efficient pharma production across the Middle East and beyond.
The event is structured around three core pillars: Engineering & Facility Design, highlighting digital transformation, cleanroom innovation, and sustainable operations; Manufacturing Excellence, focused on process optimization, technology transfer, and operational agility; and Quality & Compliance, addressing GMP readiness, validation, and sterile manufacturing best practices.
PharmaXcelerate will feature senior representatives from global leaders such as Pfizer, AstraZeneca, Sanofi, GSK, Roche, Johnson & Johnson, Merck, Novartis, and Bayer, alongside regional pioneers including Julphar, Hikma, SPIMACO, Riyadh Pharma, Jamjoom Pharma, Tabuk Pharmaceuticals, and Gulf Pharmaceutical Industries.
A distinctive element of the summit is the active participation of local pharmaceutical authorities and regulatory agencies, offering insight into national priorities, evolving standards, and regional market dynamics.
PharmaXcelerate 2026 is where the region’s pharma community connects to shape the future of resilient, high-quality, and sustainable manufacturing.
- KONEVOVA 2660/141
- 2026-03-31
- 08:00
- 2026-04-02
- 18:00
- https://tbmgroup.eu/etn/pharmaxcelerate-building-resilient-pharma-biotech-facilities-quality-systems-2/
- 212246491